Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma

Published:2012-12-11 Issue:4 Volume:160 Page:510-514
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

García-Suárez Julio¹,Flores Elena¹,Callejas Marta¹,Arribas Ignacio²,Gil-Fernández Juan-José¹,Olmedilla Gabriel³,Curto Natalia¹,Guillén Helga¹,Casco Celia-Rosalva¹,Martín Yolanda¹,Burgaleta Carmen¹

Affiliation:

1. Haematology Service; Department of Medicine; Príncipe de Asturias University Hospital; University of Alcalá; Alcalá de Henares; Madrid; Spain

2. Biomedical Research Foundation; Príncipe de Asturias University Hospital; Alcalá de Henares; Madrid; Spain

3. Pathological Anatomy Service; Príncipe de Asturias University Hospital; Alcalá de Henares; Madrid; Spain

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12144/fullpdf

Reference15 articles.

1. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma-a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL);Boehme;Annals of Oncology,2007

2. Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity;Brusamolino;Haematologica,2006

3. Revised response criteria for malignant lymphoma;Cheson;Journal of Clinical Oncology,2007

4. R-CHOP14 versus R-CHOP21: Result of a randomized phase III trial for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma;Cunningham;Journal of Clinical Oncology,2011

5. The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma;Dunleavy;Blood,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement;Journal of Clinical and Experimental Hematopathology;2020

2. Diffuse Large B-Cell Lymphomas in Older Adults;Geriatric Oncology;2020

Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

;Blood and Lymphatic Cancer: Targets and Therapy;2019-08

4. Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma – a nationwide population-based cohort study;Leukemia & Lymphoma;2019-01-22

5. Diffuse Large B-Cell Lymphomas in Older Adults;Geriatric Oncology;2018